Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2007
09/20/2007DE4003844B4 Neue Cyclosporin enthaltende galenische Formulierungen New cyclosporin-containing pharmaceutical formulations
09/20/2007DE20321512U1 Zusammensetzung zur Erleichterung der Humangeburt Composition to facilitate human childbirth
09/20/2007DE20321510U1 Kolonreinigungszusammensetzungen Kolonreinigungszusammensetzungen
09/20/2007DE102006054192A1 Method for loading nucleic acid active substances within amphoteric liposomes, comprises: mixing lipid mixture solution and aqueous solution of nucleic acid active substances; and sterile filtrating the liposomes containing the substances
09/20/2007DE102006042516A1 Verringerung eines Risikos für allerg. Reducing risk for Allergic Rhinitis. und Überempfindlichkeitsreaktionen bei Applikation des Arzneimittels Tobramycin Injektions- bzw. Infusionslösung aufgrund einer Natriummetabisulfitfreien Darreichungsform and hypersensitivity reactions in application of the drug tobramycin injection or infusion solution due to a dosage form Natriummetabisulfitfreien
09/20/2007DE102006011507A1 Wirkstoffbeladene Nanopartikel auf Basis hydrophiler Proteine Drug-loaded nanoparticles based on hydrophilic proteins
09/20/2007CA2680690A1 Apparatus and method for transdermal delivery of parathyroid hormone agents to prevent or treat osteopenia
09/20/2007CA2657932A1 Stable lozenge compositions providing rapid release of nicotine
09/20/2007CA2649261A1 Influenza infection-inhibiting peptide, influenza virus-infection inhibitor, liposome and influenza preventive/therapeutic agent
09/20/2007CA2646942A1 Improved snuff composition
09/20/2007CA2646438A1 Methods and compositions for treatment of diastolic heart failure
09/20/2007CA2646347A1 Gastric raft composition comprising preferably processed starches for inducing satiety
09/20/2007CA2646338A1 Stable nanocapsule systems for the administration of active molecules
09/20/2007CA2646230A1 Chewing gum compositions providing rapid release of nicotine
09/20/2007CA2645629A1 Orodispersible domperidone tablets
09/20/2007CA2645475A1 Solid oral form of a medicinal preparation and a method for the production thereof
09/20/2007CA2645340A1 Topical compositions in the form of an oil-in-water emulsion comprising a pro-penetrating glycol and a steroidal anti-inflammatory drug
09/20/2007CA2645339A1 Topical compositions in the form ofan oil-in-water emulsion comprising a pro-penetrant glycol and a steroidal anti-inflammatory drug
09/20/2007CA2645311A1 Aqueous composition comprising 15-keto-prostaglandin for ophthalmic use
09/20/2007CA2644784A1 Formulations of sitaxsentan sodium
09/20/2007CA2644694A1 Triggered self-assembly conjugates and nanosystems
09/20/2007CA2644429A1 Bioresorbable controlled-release composition
09/20/2007CA2644381A1 Oral hygiene products and method of using the same
09/20/2007CA2644372A1 Improved process for producing a solid dispersion of an active ingredient
09/20/2007CA2644035A1 Process for producing a solid dispersion of an active ingredient
09/20/2007CA2643431A1 A method for industrial production of biocatalysts in the form of enzymes or microorganisms immobilized in polyvinyl alcohol gel, their use and devices for their production
09/20/2007CA2643389A1 Method for solubilising, dispersing and stabilising of substances
09/20/2007CA2642504A1 Processes and apparatuses for the production of crystalline organic microparticle compositions by micro-milling and crystallization on micro-seed and their use
09/20/2007CA2626802A1 Process for making pharmaceutical compositions with a transient plasticizer
09/19/2007EP1834652A1 Dialysis preparation
09/19/2007EP1834650A1 Cancer vaccine preparation
09/19/2007EP1834638A1 Osmotic device containing amantadine and an osmotic salt
09/19/2007EP1834636A1 Compositions comprising porous articles and uses in implantable medical devices
09/19/2007EP1834635A1 Stable nanocapsule systems for the administration of active molecules
09/19/2007EP1834634A2 Pharmaceutical multiple-unit composition
09/19/2007EP1834624A1 Medicinal composition and process for producing the same
09/19/2007EP1834528A1 Process for production of jellylike drinks
09/19/2007EP1833882A1 Hyaluronic acid linked with a polymer of an alpha hydroxy acid
09/19/2007EP1833838A2 Cationic liposomes comprising a charge neutral compound and a cationic phospholipid
09/19/2007EP1833569A2 Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis
09/19/2007EP1833516A1 Particle-size reduction apparatus, and use thereof
09/19/2007EP1833503A2 Pulmonary surfactant formulations
09/19/2007EP1833497A1 Bacteriophage compositions
09/19/2007EP1833476A1 Extended release pharmaceutical composition of celecoxib
09/19/2007EP1833471A1 External patches containing etofenamate
09/19/2007EP1833470A2 Nanoparticles for protein drug delivery
09/19/2007EP1833469A2 Pharmaceutical composition of acid labile substances
09/19/2007EP1833468A1 Tablet formulation for sustained drug-release
09/19/2007EP1833467A1 Pharmaceutical compositions for sleep disorders
09/19/2007EP1833466A1 Methods for the preparation of stable pharmaceutical solid dosage forms of atorvastatin and amlodipine
09/19/2007EP1833465A2 Lyophilization of virosomes
09/19/2007EP1833464A1 Solid pharmaceutical composition comprising valsartan
09/19/2007EP1833463A1 Process for milling poorly soluble drugs in presence of liquid propellants
09/19/2007EP1833462A2 Pharmaceutical manufacturing process for heat sterilised glucocorticoid suspensions
09/19/2007EP1833461A1 Pharmaceutical formulations
09/19/2007EP1833460A2 Injectable non-aqueous suspension
09/19/2007EP1833414A2 Non-irritating compositions containing zinc salts
09/19/2007EP1750765B1 Antimycobacterial pharmaceutical composition comprising an antitubercular drug
09/19/2007EP1732524A4 Methods and compositions for treatment of ion imbalances
09/19/2007EP1656113B1 Method for the production of effervescent granules in a vacuum
09/19/2007EP1648422A4 Treatment and preventi0n of cardiovascular events
09/19/2007EP1617817B1 Oral spray to reduce cold symptoms and duration of same
09/19/2007EP1539115B1 Methods and dosage forms for controlled delivery of paliperidone
09/19/2007EP1536934A4 Method and apparatus for making miniature tablets
09/19/2007EP1453526B1 Pharmaceutical composition for topical treatment of skin disorders and skin wounds
09/19/2007EP1448165B1 Lipid carrier compositions and methods for improved drug retention
09/19/2007EP1418946B1 Bioactive surface modifiers for polymers and articles made therefrom
09/19/2007EP1408911B1 Sustained-release therapeutic bioadhesive systems
09/19/2007EP1407044B1 Rna interference mediating small rna molecules
09/19/2007EP1345593B1 Lipid microparticles by cryogenic micronization
09/19/2007EP1333819B1 Inhalative solution formulation containing a tiotropium salt
09/19/2007EP1246611B1 Formulations of active components in the form of a solid dispersion
09/19/2007EP1192134B1 Processes for the preparation of (r)-g(a)-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol
09/19/2007CN200948290Y Moxibustion patch
09/19/2007CN200948249Y Roll ointment
09/19/2007CN200948248Y Structure for adhering ointment
09/19/2007CN101039699A Methods and compositions for reducing toxicity of a pharmaceutical compound
09/19/2007CN101039689A Topical compositions and methods for epithelial-related conditions
09/19/2007CN101039665A Composition containing omega-3 fatty acids and omega-6 fatty acids
09/19/2007CN101039664A Atmosphere alteration method, and air spray and spray device used therefor
09/19/2007CN101039661A Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment
09/19/2007CN101039660A Stable pegylated interferon formulation
09/19/2007CN101039659A Granules comprising a nsaid and a sugar alcohol made by melt extrusion
09/19/2007CN101039658A Biodegradable diblock copolymers having reverse thermal gelation properties and methods of use thereof
09/19/2007CN101039657A Pharmaceutical composition comprising a solid dispersion with a polymer matrix containing a continuous polydextrose phase and a continuous phase of a polymer other than polydextrose
09/19/2007CN101039656A Enteric nutritional supplement
09/19/2007CN101037679A Nattokinase purification technique and microcapsule preparation technique
09/19/2007CN101037466A Steroid saponins and preparation method and application
09/19/2007CN101036870A Polylactide microsphere preparation by using supercritical CO2 antisolvent technology
09/19/2007CN101036787A The application of medicine composition containing proton pump inhibitor in the novel gastroenteritic compound capsule and the preparation
09/19/2007CN101036785A Chitosan nanoparticles oral preparations of hepatitis vaccine
09/19/2007CN101036782A The application and preparation of anti-inflammatory fused protein for restraining tumor necrosis factor
09/19/2007CN101036780A Application of self-assembled short peptide in the medicine for treating burn and face wound
09/19/2007CN101036778A Ginger oil for killing schistosoma japonicum cercariae
09/19/2007CN101036775A Medicine for treating dysmenorrhea
09/19/2007CN101036773A Application of compound agent in the medicine for treating fracture, tracheitis and depression for human beings
09/19/2007CN101036771A Chinese traditional medicine spray for treating pneumonia and upper respiratory infection
09/19/2007CN101036770A External emplastrum for treating deficiency-cold for children
09/19/2007CN101036769A Chinese medicine for treating coronary heart disease and angina pectoris and its preparing process
09/19/2007CN101036768A Traditional Chinese medicine for treating senile dementia and preparation process thereof